Editorial Comment: Does This Drug Make the Patient Better or Worse? Interactions between Pharmacist and Members of the Health Care Team

AIDS Reader

Volumn 13, Issue 9, 2003, Pages 446-447

  Agins, Bruce D ^a   Mojica Rogers, Carmen ^a  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; METHADONE; NEVIRAPINE;

AREA UNDER THE CURVE; CLINICAL TRIAL; DRUG METABOLISM; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PRESCRIPTION; SIDE EFFECT; TREATMENT OUTCOME; UNITED STATES; PATIENT CARE; PHARMACY; PUBLIC RELATIONS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; INTERPROFESSIONAL RELATIONS; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; UNITED STATES;

EID: 0242380249     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. Faragon JJ, Piliero PJ. Drug interactions associated with HAART: focus on treatments for addiction and recreational drugs. AIDS Reader. 2003;13:433-434, 437-441, 446-450.
2. Cantwell-McNelis K, James CW. Role of clinical pharmacists in outpatient HIV clinics. Am J Health Syst Pharm. 2002;59:447-452.
3. Columbo J. Establishing pharmaceutical care services in an HIV clinic. J Am Pharm Assoc. 1997;NS37:581-594.
4. Bramble CM, Evans BL, Shevchuck YM. Pilot project implementing pharmaceutical care and continuity of care in an ambulatory HIV clinic. Can J Hosp Pharm. 1999;52:156-161.
5. Warnock AC, Rimland D. The provision of pharmaceutical care in a Veterans' Affairs Medical Center outpatient HIV clinic. Hosp Pharm. 1994;29:114-116, 119-120.
6. Wong RJ, Volberding PA. Providing clinical pharmacy services at an AIDS-oncology ambulatory-care clinic. Am J Hosp Pharm. 1988;45:2351-2354.
7. Nolan C, McBride N, Humma G, Sorensen S. Medication display board at an HIV clinic. Am J Health Syst Pharm. 2000;57:2005-2006.